Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 11, 2020
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
[ Mon, May 11th 2020
] - WOPRAI
Sun, May 10, 2020
[ Sun, May 10th 2020
] - WOPRAI
Fri, May 8, 2020
[ Fri, May 08th 2020
] - WOPRAI
[ Fri, May 08th 2020
] - WOPRAI
Charles Duncan Reiterated (ACAD) at Buy with Increased Target to $63 on, May 8th, 2020
Charles Duncan of Cantor Fitzgerald, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $58 to $63 on, May 8th, 2020.
Charles has made no other calls on ACAD in the last 4 months.
There are 3 other peers that have a rating on ACAD. Out of the 3 peers that are also analyzing ACAD, 0 agree with Charles's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Charles
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $60 on, Thursday, April 16th, 2020
- Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $72 on, Tuesday, March 31st, 2020
- Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $69 on, Friday, March 6th, 2020
